{
    "code": "60001088",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001088",
    "time": "2021-04-23 03:23:43",
    "許可證字號": "衛部菌疫輸字第001088號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/10\/11",
    "發證日期": "107\/10\/11",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000108801",
    "中文品名": "抑癌寧注射劑",
    "英文品名": "IMFINZI Injection 50 mg\/ml",
    "適應症": "1.泌尿道上皮癌\r\n治療下列患有局部晚期或轉移性泌尿道上皮癌病人：\r\n(1)接受含鉑化療期間或治療結束後病情惡化。\r\n(2)於使用含鉑化療進行術前輔助治療，或輔助治療12個月內病情惡化。\r\n2.局部晚期非小細胞肺癌(NSCLC)：治療患有局部晚期、無法手術切除的非小細胞肺癌，且接受放射治療合併含鉑化療後病情未惡化的病人。\r\n3.小細胞肺癌：併用 etoposide以及 carboplatin 或 cisplatin 兩者之一，適用於擴散期小細胞肺癌 (ES-SCLC) 病人的第一線治療。",
    "劑型": "270注射劑",
    "包裝": "2.4毫升(vial)玻璃小瓶裝 100支以下盒裝 10毫升(vial)玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "112\/10\/11",
    "主成分略述": "Durvalumab",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0559000  VETTER PHARMA-FERTIGUNG GMBH &amp; CO KG",
            "製造廠廠址": "MOOSWIESEN 2, 88214 RAVENSBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "成品製造廠"
        },
        {
            "製造廠名稱": "FUS1133000  Catalent Indiana, LLC",
            "製造廠廠址": "1300 S.Patterson Dr.Bloomington, IN 47403, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "成品及包裝廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FSE0032000  ASTRAZENECA AB",
            "製造廠廠址": "SE-151 85 SODERTALJE SWEDEN",
            "製造廠公司地址": "",
            "製造廠國別": "SWEDEN",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS0980100  ASTRAZENECA PHARMACEUTICALS LP",
            "製造廠廠址": "FREDERICK MANUFACTURING CENTER, 633 RESEARCH COURT, MD 21703, FREDERICK, US",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013007200",
            "成分名稱": "Durvalumab",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG\/ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "Imfinzi_printed PI-ZH-TW-MG-USPI-110-03-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=008&Type=9"
        },
        {
            "title": "500mg-108-07-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=009&Type=8"
        },
        {
            "title": "120mg-108-07-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=008&Type=8"
        },
        {
            "title": "IMFINZI 500mg 1x10ml-標籤-PS13177-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=007&Type=8"
        },
        {
            "title": "IMFINZI 500mg 1x10ml-外盒-PS15783-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=006&Type=8"
        },
        {
            "title": "IMFINZI 120mg 1x2.4ml-標籤-PS13176-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=005&Type=8"
        },
        {
            "title": "IMFINZI 120mg 1x2.4ml-外盒-PS15782-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=004&Type=8"
        },
        {
            "title": "4-4. Imfinzi 500mg-外盒-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=003&Type=8"
        },
        {
            "title": "4-3. Imfinzi 120mg-標籤-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=002&Type=8"
        },
        {
            "title": "4-2. Imfinzi 120mg-外盒-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001088&Seq=001&Type=8"
        }
    ]
}